Lithium induces mortality in medulloblastoma cell lines

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 745-752

  Ronchi, Alice ^a   Salaroli, Roberta ^a   Rivetti, Stefano ^a   Bella, Elena Della ^a   Di Tomaso, Tiziano ^a   Voltattorni, Manuela ^a   Cammelli, Silvia ^a   Ceccarelli, Claudio ^a   Giangaspero, Felice ^b,c   Barbieri, Enza ^a   Cenacchi, Giovanna ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Glycogen synthase kinase 3 ; Lithium chloride; Medulloblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; LITHIUM CHLORIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

CELL DEATH; CELL GROWTH PROCESSES; CELL LINE, TUMOR; ENZYME ACTIVATION; GENES, P53; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; MEDULLOBLASTOMA; MUTATION; WNT PROTEINS;

EID: 77956504016     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000724     Document Type: Article

References (33)

1. Severus WE, Kleindestein N, Seemuler F, Frangou S, Moller HJ and Greil W: What is the optimal serum lithium level in the long-term treatment of bipolar disorder - a review? Bipolar Disord 10: 231-237, 2008.
2. Phiel CJ and Klein PS: Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41: 789-813, 2001.
3. Williams R, Ryves WJ, Dalton EC, Eickholt B, Shaltiel G, Agam G and Harwood AJ: A molecular cell biology of lithium. Biochem Soc Trans 32: 799-802, 2004.
4. Smits VA, Essers MA, Loomans DS, Klompmaker R, Rijksen G and Medema RH: Inhibition of cell proliferation by lithium is associated with interference in cdc2 activation. FEBS Lett 457: 23-27, 1999.
5. Mao CD, Hoang P and DiCorleto PE: Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. J Biol Chem 276: 26180-26188, 2001. (Pubitemid 33730684)
6. Karlovic D, Jakopec S, Dubravcic K, Batinic D, Buljan D and Osmak M: Lithium increases expression of p21(WAF/Cip1) and survivin in human glioblastoma cells. Cell Biol Toxicol 23: 83-90, 2007.
7. Sun A, Shanmugam I, Song J, Terranova PF, Thrasher JB and Li B: Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Prostate 67: 976-988, 2007.
8. Song L, Zhou T and Jope RS: Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 5: 20, 2004. (Pubitemid 38729179)
9. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ and Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170: 1101-1111, 2005.
10. Zhang WV, Jüllig M, Connolly AR and Stott NS: Early gene response in lithium chloride induced apoptosis. Apoptosis 10: 75-90, 2005. (Pubitemid 40558116)
11. Welshons WV, Engler KS, Taylor JA, Grady LH and Curran EM: Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. J Cell Physiol 165: 134-144, 1995.
12. Penso J and Beitner R: Lithium detaches hexokinase from mitochondria and inhibits proliferation of B16 melanoma cells. Mol Genet Metab 78: 74-78, 2003.
13. Erdal E, Ozturk N, Cagatay T, Eksioglu-Demiralp E and Ozturk M: Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int J Cancer 115: 903-910, 2005. (Pubitemid 40791830)
14. Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA and Lawler S: Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10: 690-699, 2008.
15. D'Mello SR, Anelli R and Calissano P: Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 211: 332-338, 1994.
16. Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ and Coffey ET: Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 23: 6027-6036, 2003.
17. Chen RW and Chuang DM: Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274: 6039-6042, 1999.
18. Manji HK, Moore GJ and Chen G: Lithium upregulates the cytoprotective protein Bcl-2 in vitro and in the CNS in vivo: a role of neurotrophic and neuroprotective effects in maniac-depressive illness. J Clin Psychiatry 61: 82-96, 2000.
19. Kang HJ, Noh JS, Bae YS and Gwag BJ: Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cgamma. Mol Pharmacol 64: 228-234, 2003.
20. Klein PS and Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459, 1996.
21. Cohen P and Goedert M: GSK-3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3: 479-487, 2004. (Pubitemid 38807530)
22. Jope RS and Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102, 2004.
23. Kim L and Kimmel AR: GSK-3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev 10: 508-514, 2000.
24. Stambolic V, Ruel L and Woodgett JR: Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells. Curr Biol 6: 1664-1668, 1996.
25. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD and Clifford SC: Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumor Committee. J Clin Oncol 23: 7951-7957, 2005.
26. Clifford SC, Lusher ME, Lindsey JC, Langdon JA, Gilbertson RJ, Straughton D and Ellison DW: Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5: 2666-2670, 2006.
27. Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, Manie E, Raquin MA, Bours D, Carpentier S, Barillot E, Grill J, Doz F, Puget S, Janoueix-Lerosey I and Delattre O: Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218: 86-94, 2009.
28. Salaroli R, Russo A, Ceccarelli C, Mina GD, Arcella A, Martinelli GN, Giangaspero F, Capranico G and Cenacchi G: Intracellular distribution of beta-catenin in human medulloblastoma cell lines with different degree of neuronal differentiation. Ultrastruct Pathol 31: 33-44, 2007.
29. Salaroli R, Di Tomaso T, Ronchi A, Ceccarelli C, Cammelli S, Cappellini A, Martinelli GN, Barbieri E, Giangaspero F and Cenacchi G: Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? J Neurooncol 90: 243-251, 2008.
30. Belka C: The fate of irradiated tumor cells. Oncogene 25: 969-971, 2006.
31. Tasdemir E, Chiara Maiuri M, Morselli E, Criollo A, D'Amelio M, Djavaheri-Mergny M, Cecconi F, Tavernarakis N and Kroemer G: A dual role of p53 in the control of autophagy. Autophagy 4: 810-814, 2008.
32. Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, Muto A, Oya M, Billadeau D, Motoyama T and Tomita Y: Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. Br J Cancer 101: 2005-2014, 2009.
33. Mamaghani S, Patel S and Hedley DW: Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. BMC Cancer 9: 132, 2009.